Literature DB >> 6243178

Is prostacyclin a physiologically important circulating anti-platelet agent?

M L Steer, D E MacIntyre, L Levine, E W Salzman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6243178     DOI： 10.1038/283194a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

Review 1.  Arachidonate metabolism in vascular disorders.

Authors:  P W Majerus
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

Review 2.  Prostaglandins in vascular disease: a seminal approach.

Authors:  J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-21

Review 3.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

4.  Release of prostacyclin from the human pulmonary vascular bed in response to cholinergic stimulation.

Authors:  R Brandt; A Dembińska-Kieć; R Korbut; R J Gryglewski; J Nowak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

5.  Inhibition of platelet function by a controlled release acetylsalicylic acid formulation--single and chronic dosing studies.

Authors:  M S Roberts; L J McLeod; P A Cossum; J H Vial
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 6.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

7.  Different effects of furosemide on alpha-adrenoceptors and on platelet aggregation in man.

Authors:  A Kribben; E Fritschka; M Sibold; M Fassbender; M Rothschild; A Distler; T Philipp
Journal:  Klin Wochenschr       Date:  1988-07-15

8.  In-vitro venous prostacyclin production, plasma 6-keto-prostaglandin F1 alpha concentrations, and diabetic retinopathy.

Authors:  T M Davis; E Bown; D R Finch; M D Mitchell; R C Turner
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-18

9.  Factors that influence the outcome of primary pulmonary hypertension.

Authors:  A Rozkovec; P Montanes; C M Oakley
Journal:  Br Heart J       Date:  1986-05

10.  Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.

Authors:  M Vanderwel; R J Haslam
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.